Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Open-Label, Multi-Country, Multicentre, Observational PoSt Market SurvEillance of VIVO ISAR (Polymer-Free Sirolimus Eluting Coronary Stent System) In Real World Patients Undergoing PCI With Short Dual Antiplatelet Therapy

NCT06412250 is registered in ClinicalTrials.gov with Translumina Therapeutics Pvt Ltd. as lead sponsor.

NCT NCT06412250
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06412250 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Open-Label, Multi-Country, Multicentre, Observational PoSt Market SurvEillance of VIVO ISAR (Polymer-Free Sirolimus Eluting Coronary Stent System) In Real World Patients Undergoing PCI With Short Dual Antiplatelet Therapy
Lead sponsor
Translumina Therapeutics Pvt Ltd.
Phase
Observational
Overall status
Recruiting
Start date
January 10, 2024
Completion date
November 30, 2027
Enrollment
2,000 (estimated)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular diseases